asimadoline,
EMD 61 753,
EMD 61753,
EMD-61 753,
EMD-61753,
N-methyl-N--(1-phenyl-2-(3-hydroxypyrrolidin-1-yl)ethyl)-2,2-diphenylacetamide hydrochloride,
Asimadoline,
153205-46-0,
EMD 61753,
EMD-61753,
Asimadoline HCl,
UNII-D0VK52NV5M,
D0VK52NV5M,
Asimadoline [INN],
185951-07-9,
Asimadoline (EMD-61753,
SCHEMBL155020,
AC1L452B,
GTPL9279,
CHEMBL1190199,
AOB5356,
DTXSID60165285,
ZINC3800054,
BDBM50366356,
MFCD00925628,
AKOS027327580,
CS-8053,
DB05104,
EMD 61 753,
SB16969,
N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide,
NCGC00408844-01,
AS-16871,
CC-24193,
HY-107384,
FT-0773773,
A16920,
C-23855,
Benzeneacetamide, N-((1S)-2-((3S)-3-hydroxy-1-pyrrolidinyl)-1-phenylethyl)-N-methyl-alpha-phenyl-,
Benzeneacetamide, N-(2-(3-hydroxy-1-pyrrolidinyl)-1-phenylethyl)-N-methyl-alpha-phenyl-, (S-(R*,R*))-,
N-((alpha S)-alpha-((3S)-3-Hydroxy-1-pyrrolidinyl)methyl)benzyl)-N-methyl-2,2-diphenylacetamide,
N-((alphaS)-alpha-(((3S)-3-Hydroxy-1-pyrrolidinyl)methyl)benzyl)-N-methyl-2,2-diphenylacetamide,
N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-di(phenyl)acetamide,
D07TQN,
ASIMADOLINE HYDROCHLORIDE,
CID179340,
C27-H30-N2-O2,
N-((S)-2-((S)-3-Hydroxypyrrolidin-1-yl)-1-phenylethyl)-N-methyl-2,2-diphenylacetamide,
N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxy-1-pyrrolidino)ethyl]-2-diphenylacetamide,
N-[(1S)-2-[(3S)-3-Hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-alpha-phenylbenzene-nu-acetamide,